These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32579877)

  • 1. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients.
    Choe PG; Kang CK; Suh HJ; Jung J; Kang E; Lee SY; Song KH; Kim HB; Kim NJ; Park WB; Kim ES; Oh MD
    Emerg Infect Dis; 2020 Oct; 26(10):2484-2487. PubMed ID: 32579877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection.
    Lin Q; Zhu L; Ni Z; Meng H; You L
    J Microbiol Immunol Infect; 2020 Oct; 53(5):821-822. PubMed ID: 32249185
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid Screening Evaluation of SARS-CoV-2 IgG Assays Using Z-Scores to Standardize Results.
    Das MK; Chaudhary A; Bryan A; Wener MH; Fink SL; Morishima C
    Emerg Infect Dis; 2020 Oct; 26(10):2501-2503. PubMed ID: 32723430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
    Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic testing of coronaviruses from MERS-CoV to SARS-CoV-2: Learning from the past and anticipating the future.
    Al-Tawfiq JA; Memish ZA
    Travel Med Infect Dis; 2020; 37():101785. PubMed ID: 32534208
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.
    Okba NMA; Müller MA; Li W; Wang C; GeurtsvanKessel CH; Corman VM; Lamers MM; Sikkema RS; de Bruin E; Chandler FD; Yazdanpanah Y; Le Hingrat Q; Descamps D; Houhou-Fidouh N; Reusken CBEM; Bosch BJ; Drosten C; Koopmans MPG; Haagmans BL
    Emerg Infect Dis; 2020 Jul; 26(7):1478-1488. PubMed ID: 32267220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity.
    Padoan A; Zuin S; Cosma C; Basso D; Plebani M; Bonfante F
    Clin Chim Acta; 2020 Nov; 510():654-655. PubMed ID: 32818490
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data.
    Naaber P; Hunt K; Pesukova J; Haljasmägi L; Rumm P; Peterson P; Hololejenko J; Eero I; Jõgi P; Toompere K; Sepp E
    PLoS One; 2020; 15(10):e0237548. PubMed ID: 33108380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives.
    Infantino M; Damiani A; Gobbi FL; Grossi V; Lari B; Macchia D; Casprini P; Veneziani F; Villalta D; Bizzaro N; Cappelletti P; Fabris M; Quartuccio L; Benucci M; Manfredi M
    Isr Med Assoc J; 2020 Apr; 22(4):203-210. PubMed ID: 32286019
    [No Abstract]   [Full Text] [Related]  

  • 11. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
    Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
    [No Abstract]   [Full Text] [Related]  

  • 12. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.
    Premkumar L; Segovia-Chumbez B; Jadi R; Martinez DR; Raut R; Markmann A; Cornaby C; Bartelt L; Weiss S; Park Y; Edwards CE; Weimer E; Scherer EM; Rouphael N; Edupuganti S; Weiskopf D; Tse LV; Hou YJ; Margolis D; Sette A; Collins MH; Schmitz J; Baric RS; de Silva AM
    Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32527802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Acute Respiratory Syndrome Coronavirus 2 among Asymptomatic Workers Screened for Work Resumption, China.
    Han X; Wei X; Alwalid O; Cao Y; Li Y; Wang L; Shi H
    Emerg Infect Dis; 2020 Sep; 26(9):2265-7. PubMed ID: 32553070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can dried blood spots (DBS) contribute to conducting comprehensive SARS-CoV-2 antibody tests?
    Thevis M; Knoop A; Schaefer MS; Dufaux B; Schrader Y; Thomas A; Geyer H
    Drug Test Anal; 2020 Jul; 12(7):994-997. PubMed ID: 32386354
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum IgA, IgM, and IgG responses in COVID-19.
    Ma H; Zeng W; He H; Zhao D; Jiang D; Zhou P; Cheng L; Li Y; Ma X; Jin T
    Cell Mol Immunol; 2020 Jul; 17(7):773-775. PubMed ID: 32467617
    [No Abstract]   [Full Text] [Related]  

  • 16. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.
    Phipps WS; SoRelle JA; Li QZ; Mahimainathan L; Araj E; Markantonis J; Lacelle C; Balani J; Parikh H; Solow EB; Karp DR; Sarode R; Muthukumar A
    Am J Clin Pathol; 2020 Sep; 154(4):459-465. PubMed ID: 32666092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Promise and Peril of Antibody Testing for COVID-19.
    Abbasi J
    JAMA; 2020 May; 323(19):1881-1883. PubMed ID: 32301958
    [No Abstract]   [Full Text] [Related]  

  • 18. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
    Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
    J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.